ArticleBMC medical genomics2014

Whole genome sequencing reveals potential targets for therapy in patients with refractory KRAS mutated metastatic colorectal cancer.

Vijayalakshmi Shanmugam et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.